NuCana plc (NCNA) ADR Each Representing 0.0002 Ord Shares SPON

Sell:$2.01Buy:$2.10Price decreased$0.11 (5.12%)

Prices delayed by at least 15 minutes
Sell:$2.01
Buy:$2.10
Change:Price decreased$0.11 (5.12%)
Deal now
Prices delayed by at least 15 minutes
Sell:$2.01
Buy:$2.10
Change:Price decreased$0.11 (5.12%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$2.12
Previous close$2.15
Market cap$9.20m
P/E ratio-
Volume37,885
Dividend yield0.00%
EMS-

Company information

NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue0.00
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.